Ọrụ mbufe teknụzụ paclitaxel na-ejikọta Albumin

Nkọwa dị mkpirikpi:

Paclitaxel bụ ọgwụ mgbochi tumor nke a na-ejikarị eme ihe. Ngwunye paclitaxel nke a na-eji ugbu a na omume ụlọ ọgwụ na-eji mmanụ polyoxyethylene castor dị ka solubilizer, mana mmeghachi omume ọjọọ na-adị elu mgbe a na-eji ya eme ihe n'ụlọ ọgwụ, ya mere onye ọrịa kwesịrị ịmalite ọgwụgwọ ọrịa nrịanrịa tupu nchịkwa. nke na-eweta ọtụtụ nsogbu nye ndị ọrịa na ndị dọkịta. Iji kpochapụ mmeghachi omume ọjọọ nke mmanụ polyoxyethyl castor na-akpata, merie ntụpọ nke nkwadebe ndị dị ugbu a, ma mee ka solubility na nkwụsi ike nke paclitaxel pụta, albumin-bound paclitaxel bịara.

Zitere anyị email

Nkọwa ngwaahịa

Mkpado ngwaahịa

Ozi ngwaahịa

Aha:paclitaxel na-ejikọta albumin

Ihe na-arụ ọrụ:Paclitaxel

Ihe enyemaka:albumin mmadụ

Ụdị ihe owuwu:

Ngosipụta

Ọ na-adabara maka ọgwụgwọ ọrịa cancer metastatic nke na-adaba na chemotherapy jikọtara ma ọ bụ ọrịa ara ara nke na-alọghachi n'ime ọnwa 6 mgbe ọgwụgwọ adjuvant chemotherapy gasịrị. Ọ gwụla ma enwere contraindications ụlọ ọgwụ, chemotherapy gara aga kwesịrị ịgụnye ọgwụ anthracycline anticancer; A na-eji carboplatin jikọtara ọnụ maka ahịrị mbụ. ọgwụgwọ nke ọrịa cancer akpa ume na mpaghara ma ọ bụ metastatic na-abụghị obere cell nke na-adabaghị maka ịwa ahụ ma ọ bụ ọgwụgwọ redio na ndị okenye; Nchikota gemcitabine maka ọgwụgwọ mbụ nke ndị okenye metastatic ọrịa cancer pancreatic, ọrịa cancer pancreatic. Na mgbakwunye, ọ na-emetụtakwa melanoma metastatic. na platinum mmetụta ma ọ bụ platinum na-eguzogide ọrịa cancer ovarian ugboro ugboro.

Ọrụ anyị

Yunnan Hande Bio-Tech Co., Ltd e specializing na mmepụta nke paclitaxel API ihe karịrị 20 afọ, na bụ otu n'ime ụwa na-eduga emepụta nke paclitaxel API na FDA ihu ọma, CEP akwụkwọ na GMP akwụkwọ na China.Hande nwere ike inye. ọ bụghị naanị paclitaxel API dị elu kamakwa ọrụ nyefe teknụzụ maka paclitaxel albumin. Maka ozi ndị ọzọ, biko nweere onwe gị ịkpọtụrụ anyị na 18187887160.